medsci-skills 4.1.0

package/skills/write-paper/references/journal_profiles/JCSM.md

@@ -0,0 +1,266 @@
+# Journal Profile: Journal of Cachexia, Sarcopenia and Muscle (JCSM)
+
+## Basic Information
+
+- **Publisher:** Wiley
+- **Frequency:** Continuous publication (online articles published directly into online issue when ready; no issue curation or pagination delay)
+- **Impact Factor:** [TODO: verify at JCSM journal page — recent JCR year]
+- **ISSN:** [TODO: verify at JCSM journal page — print / online]
+- **Scope:** Cachexia, sarcopenia, body composition, and physiological/pathophysiological changes in skeletal muscle and fat tissue across the lifespan and in chronic illness (AIDS, cancer, chronic heart failure, chronic lung disease, liver cirrhosis, chronic kidney failure, rheumatoid arthritis, sepsis). Strong reception for diagnostic/assessment biomarker validation and mechanistic muscle-wasting and lipolysis studies.
+- **Open Access:** Gold Open Access — articles immediately free to read, download, and share after publication
+- **APC (Article Processing Charge):** Required upon acceptance; waivers/discounts may apply via institution, funder, or country waiver — see journal's Open Access page
+- **Language:** English only
+- **Acceptance rate:** [TODO: verify at JCSM journal page]
+
+---
+
+## Manuscript Types and Word Limits
+
+| Type | Body Word Limit | Abstract | References | Figures/Tables |
+|------|----------------|----------|------------|----------------|
+| Original Article | 4,500 (excluding abstract, references, tables, figures) | 400 words (structured, data-rich) | 40 (main); additional as supplement (S1, S2, ...) | 8 (max 6 sub-sections per figure, labelled a–f) |
+| Review | 6,000 (excluding abstract, references, tables, figures) | 400 words (unstructured but data/information-rich) | 120 (main); additional as supplement | 8 (max 6 sub-sections per figure) |
+| Editorial (by invitation only) | 1,500 | None typically (Facts & Numbers series: up to 400 words, data-rich) | 20 (exceptions for Facts & Numbers and statistical analyses) | 1–2 |
+| Research/Scientific Letter | 1,200 | n/a | 10 | 1 figure or table |
+| Short Report | 1,500 | n/a | 10 | up to 2 figures or tables |
+| Meeting Report | 1,500 | n/a | 20 | n/a |
+| Reply / Letters to the Editor | 1,200 | n/a | [TODO: verify] | [TODO: verify] |
+
+**Title length cap:** maximum 17 words OR 120 characters (whichever is shorter).
+
+---
+
+## Abstract Requirements (Original Article)
+
+**Structured abstract, ≤400 words, data-rich:**
+
+```
+Background: [Context and aim]
+Methods: [Design, population, intervention/exposure, comparator, outcomes, statistical approach]
+Results: [Numbers (cohort size, % female, mean age ± SD), percentages, percent differences,
+         correlations, hazard or odds ratios with 95% CIs, key p-values supporting main messages]
+Conclusions: [Main conclusion grounded in the results]
+```
+
+**Critical guidance from the journal:**
+- "Descriptive results abstracts are not acceptable" — must include actual numbers, effect sizes, p-values
+- For clinical studies, always mention N, % female, mean age ± SD
+- Omit filling words ("thus", "therefore", "moreover")
+- Minimize abbreviations in abstract and conclusion
+- "If in doubt, add more data rather than less"
+
+**Keywords:** 4–6 for indexing.
+
+---
+
+## Required Sections (Original Article)
+
+Article order:
+
+1. **Title page** — name(s), title (≤17 words / 120 chars), affiliation(s), corresponding-author email/phone/fax
+2. **Abstract** — structured (see above)
+3. **Keywords** — 4–6
+4. **Introduction**
+5. **Methods**
+6. **Results**
+7. **Discussion**
+8. **Acknowledgements** — funding, conflict of interest, ethical guidelines statement
+
+**Headings:** maximum 3 levels of displayed headings.
+
+---
+
+## Corresponding Author Policy (JCSM-specific)
+
+- **Only ONE corresponding author per submission.** The corresponding author is the sole contact and the only author who can access/modify the manuscript during editorial review.
+- **No post-acceptance authorship changes** — including adding/removing authors, changing the corresponding author, designating multiple first authors, or adjusting author order.
+- **Multiple co-first / equal contributions** — must be declared in the cover letter at submission; approval at Editor's discretion.
+
+**Manuscript-design implication:** if your study has co-corresponding authors at submission (common in observational research), only one can be the technical corresponding author; the other must be designated as a senior author with footnote acknowledgement.
+
+---
+
+## Ethical Standards
+
+- Helsinki Declaration adherence statement required
+- IRB approval statement required
+- Informed consent statement required (or waiver justification)
+- "The manuscript does not contain clinical studies or patient data" — required if not applicable
+- Identity-disclosing details must be omitted
+
+---
+
+## Statistical Reporting — JCSM-specific for Survival / Prognostic Studies
+
+JCSM enforces stricter survival-cohort reporting than most journals. **Applies to "Studies describing survival rates and prognostic associations":**
+
+- **Mandatory event reporting (in BOTH abstract AND methods/results):**
+  - Number of events observed in the overall cohort
+  - **1-year mortality rate with 95% CI**
+  - **5-year mortality rate with 95% CI** (if appropriate)
+  - **3-month mortality rate with 95% CI** (if appropriate)
+  - These serve "to assess the power of the study"
+- **Cohort size guidance:**
+  - **Novel prognostic markers**: cohort with ≥60–100 events
+  - **Novel prognostic scores**: cohort with ≥150–200 events
+  - **Validation in second cohort** strongly recommended for cutoffs derived from primary cohort
+- **Kaplan-Meier survival graphs**: must display number of "patients at risk" for each group at baseline and at follow-up intervals
+- **Figure legend or in-figure** for survival plots must include: HR or rate ratios with 95% CI and p-values, plus total number of events
+- **Clinical trials**:
+  - Pre-registered before start (provide NCT number etc.)
+  - ITT analysis for efficacy (other methods for safety / non-inferiority)
+  - One primary efficacy endpoint (or alpha-splitting / Hochberg justification)
+  - Statistical analysis plan in English submitted
+  - Trial protocol in English as appendix
+
+---
+
+## Reporting Guidelines
+
+JCSM does not enumerate a single mandatory checklist on the author guidelines page but enforces survival-cohort-specific reporting (see above). Standard reporting guideline adherence (STROBE for observational cohorts, CONSORT for trials, PRISMA for systematic reviews) is expected per general publication ethics.
+
+---
+
+## Figures and Tables
+
+- **Maximum:** 8 figures and/or tables within the manuscript (additional as Supporting Information, no limit)
+- **Sub-sections per figure:** max 6, labelled a–f
+- **Submit figures/tables as separate individual files**, not embedded in manuscript (due to quality)
+- **Vector graphics preferred:** EPS for line art / vector; TIFF for halftones; MS Office acceptable
+- **Resolution:**
+  - Line art (bitmap): ≥1,200 DPI
+  - Halftones: ≥300 DPI
+  - Combination (halftone + line + lettering): ≥600 DPI
+- **Color:** Free of charge for online; submit as RGB (8 bits per channel)
+- **Lettering:** Helvetica or Arial sans-serif, 2–3 mm (8–12 pt) at final size, consistent within figure
+- **Figure captions:** in text file, begin with "Fig." in bold + figure number in bold (no punctuation after number)
+- **Accessibility:**
+  - Descriptive captions for all figures
+  - Use patterns in addition to colors (colorblind-friendly)
+  - Lettering contrast ratio ≥4.5:1
+
+---
+
+## References
+
+- **Limits:** 40 for Original Article; 120 for Review (main manuscript)
+- **Overflow:** additional references as Supporting Information, numbered S1, S2, S3 ...
+- **Selection guidance:** journal discourages cutting list at 40/120 without curation; the supplement is for "secondary importance" references
+- **Citation style:** numerical in square brackets — `[3]`, `[5]`, `[1–3, 7]`
+- **Reference style (as of August 15, 2024):** no submission requirement for formatting; consistent style throughout manuscript with: author(s), journal/book title, article title (where applicable), year, volume/issue, pagination, DOI (optional). Journal will reformat to house style upon acceptance.
+
+---
+
+## Preprints
+
+Posting to community preprint servers (arXiv, bioRxiv, etc.) by the author is **permitted** and does not preclude publication. Requirements:
+
+- Identify the preprint server and accession #/DOI in the cover letter at submission
+- Upon publication, request that the preprint server adds the published-journal reference (with DOI link) to its record
+
+---
+
+## File Format and Formatting
+
+- **Manuscript file:** Word `.docx` (Word 2007+) or `.doc` (older); LaTeX accepted for math-heavy submissions
+- **Fonts:** Times Roman 10-point or equivalent plain font for text
+- **Italics:** for emphasis
+- **Pagination:** automatic page-numbering function
+- **Indents:** tab stops or commands, not space bar
+- **Tables:** table function, not spreadsheets
+- **Equations:** equation editor or MathType
+- **Footnotes:** use footnotes, not endnotes; consecutively numbered; not solely a reference citation
+- **Field functions:** do NOT use
+
+---
+
+## Cover Letter
+
+Should include:
+
+- Confirmation that work has not been published before and is not under consideration elsewhere
+- Confirmation that publication has been approved by all co-authors
+- Preprint declaration if applicable (server name + accession/DOI)
+- Co-first or equal-contribution designation requests
+- Conflict of interest summary
+- Permissions evidence if any previously-published figures/tables/text are reused
+
+---
+
+## AI Writing Disclosure Policy
+
+[TODO: verify at JCSM journal page + Wiley publisher AI policy — not enumerated on this Author Guidelines page]
+
+Wiley publisher-wide AI policy generally requires:
+- Disclosure of AI-assisted tools used in manuscript preparation in Methods or Acknowledgements
+- AI cannot be listed as author
+- AI-generated images typically banned or require explicit disclosure
+- Refer to Wiley's "Best Practice Guidelines on Research Integrity and Publishing Ethics" for current AI policy at the time of submission
+
+---
+
+## Peer Review
+
+**Single-blind peer review** — reviewers know author identities but authors do not know reviewer identities.
+
+All articles undergo rigorous peer review prior to acceptance.
+
+---
+
+## Common Rejection Reasons
+
+[TODO: verify with editorial office]
+
+Risks specific to JCSM author-guideline strict requirements:
+1. **Descriptive abstract without numbers** — JCSM explicitly states "descriptive results abstracts are not acceptable"; 400-word data-rich structure with effect sizes, CIs, p-values is mandatory
+2. **Missing 1-year / 5-year mortality rates with 95% CI** for survival or prognostic studies — required in both abstract and methods/results
+3. **Underpowered prognostic cohort** — novel prognostic markers expected from cohorts with ≥60–100 events; novel prognostic scores require ≥150–200 events
+4. **Missing Kaplan-Meier "patients at risk" annotation** — KM plots without numbers-at-risk at baseline and follow-up intervals are returned
+5. **Title overrun** — title >17 words or >120 characters returned for revision
+6. **Word count overrun** — Original Article >4,500 body words (excluding abstract, refs, tables, figures) flagged
+7. **Multiple corresponding authors at submission** — only one allowed; co-corresponding requests must be declared and approved in cover letter
+8. **Out of scope** — manuscripts without clear connection to cachexia, sarcopenia, body composition, or muscle/fat tissue pathophysiology may be deprioritized
+
+---
+
+## Submission Portal
+
+https://authors.wiley.com/journal/JCSM/
+
+---
+
+## Author Guidelines URL
+
+https://onlinelibrary.wiley.com/page/journal/13989440/homepage/forauthors.html
+
+---
+
+## Positioning
+
+JCSM is well-suited for:
+- Body composition cohort studies with metabolic, functional, or mortality outcomes
+- Sarcopenia and cachexia clinical and mechanistic research
+- Diagnostic biomarker validation for muscle wasting
+- Imaging-defined body-composition phenotype × clinical-outcome research
+- Skeletal-muscle and adipose-tissue mechanism studies
+- Prognostic marker / score studies meeting the 60–200 events cohort requirement
+
+**Cascade considerations:** Suitable as a primary submission target for body composition × metabolic outcome research with adequate event count and survival reporting. Cascade to Diabetologia (EASD), Diabetes Care (ADA), or Korean-society journals (DMJ, EnM) for body-composition or metabolic-outcome research that does not meet JCSM's strict prognostic-cohort thresholds.
+
+| Dimension | JCSM | Diabetologia | Lancet Diabetes & Endocrinology |
+|-----------|------|---------------|--------------------------------|
+| Society | Wiley (specialty) | EASD | Lancet family |
+| Scope | Cachexia / sarcopenia / body composition / muscle | Diabetes mechanism + RCT | Diabetes high-impact global RCT/cohort |
+| Word budget (Original) | 4,500 | [TODO: verify] | [TODO: verify] |
+| Abstract | 400 (structured, data-rich) | [TODO: verify] | [TODO: verify] |
+| References (Original) | 40 main + unlimited supplement | [TODO: verify] | [TODO: verify] |
+| Survival reporting | Strict (1-yr/5-yr mortality, patients-at-risk, ≥60–100 events for novel markers) | [TODO: verify] | [TODO: verify] |
+| Peer review | Single-blind | [TODO: verify] | [TODO: verify] |
+| OA model | Gold OA, APC required | [TODO: verify] | [TODO: verify] |
+
+
+---
+
+## Verification
+- **Source:** https://onlinelibrary.wiley.com/page/journal/13989440/homepage/forauthors.html
+- **Date:** 2026-05-21

package/skills/write-paper/references/journal_profiles/JKMS.md

@@ -0,0 +1,201 @@
+# Journal Profile: Journal of Korean Medical Science (JKMS)
+
+## Basic Information
+
+- **Publisher:** Korean Academy of Medical Sciences (KAMS)
+- **Editor-in-Chief:** Jin-Hong Yoo, MD PhD
+- **Frequency:** Weekly, online-only
+- **Impact Factor:** ~3.0 (recent years; verify at jkms.org)
+- **ISSN:** 1011-8934 (print, legacy) / 1598-6357 (electronic)
+- **Scope:** General medical journal covering all medical specialties — clinical and basic science, public health, epidemiology. Particular receptivity to Korean and Asian population studies.
+- **Open Access:** Yes — fully open access; indexed in PubMed/MEDLINE, SCIE, Scopus
+- **APC (Article Processing Charge):** Charged on acceptance (verify current rate at jkms.org); editing fee for graphical abstracts included in APC
+- **Language:** English only (manuscripts and submission)
+
+---
+
+## Manuscript Types and Word Limits
+
+| Type | Body Word Limit | Abstract | Figures | References |
+|------|----------------|----------|---------|------------|
+| Original Article | 3000 words | 350 words (structured) | ≤6 | No explicit limit (verify) |
+| Review Article (invited) | None specified | 350 words (unstructured) | ≤6 | No explicit limit |
+| Brief Communication | 1500 words | 150 words (unstructured) | ≤3 | Reduced |
+| Case Report | 1500 words | 150 words (unstructured) | ≤4 | Reduced |
+| Case Conference (CME) | 2500 words | n/a | ≤6 | Standard |
+| Guideline / Editorial / Opinion | 600–1500 words | variable | n/a | n/a |
+| Correspondence | 600 words | None | 1 | Limited |
+
+---
+
+## Abstract Requirements (Original Article)
+
+**Structured abstract, 350 words maximum:**
+
+```
+Background: [Context and aim]
+Methods: [Design, population, intervention/index, comparator, outcomes, statistical approach]
+Results: [Primary outcome with effect sizes and 95% CIs; key secondary findings]
+Conclusion: [Main conclusion grounded in the results]
+```
+
+**Keywords:** 5–6 MeSH-aligned terms after the abstract.
+
+---
+
+## Required Sections (Original Article)
+
+JKMS uses standard IMRAD structure:
+
+1. **Introduction**
+2. **Methods**
+   - IRB approval and informed consent statement required
+   - Helsinki Declaration adherence required for human subjects research
+   - Trial registration mandatory for clinical trials (WHO ICTRP, ClinicalTrials.gov, KCRIS, or equivalent)
+3. **Results**
+4. **Discussion**
+5. **Conclusion** (often as the final paragraph of Discussion)
+
+Additional title-page-level requirements: Author affiliations with full postal address, ORCID for each author, Funding statement, Conflicts of Interest, Author Contributions, Acknowledgements, Data Availability Statement (mandatory for submissions after July 2018 per ICMJE).
+
+---
+
+## Ethics Statement
+
+**Human subjects (template):**
+"This study was approved by the Institutional Review Board of [Institution] (approval number: [XXX]). The requirement for informed consent was [waived/obtained] given the [retrospective design / prospective design]. The study was conducted in accordance with the principles of the Declaration of Helsinki."
+
+**Animal studies:**
+"All experiments were approved by the Institutional Animal Care and Use Committee of [Institution] (approval number: [XXX]) and were conducted in accordance with relevant guidelines."
+
+**Clinical trials:** Registration number must be reported with the registry name and URL.
+
+---
+
+## Statistical Reporting
+
+- **P-values:** Report exact values to 3 decimal places (for example, P = 0.031), italicized; not "P < 0.05".
+- Values below 0.001 reported as P < 0.001.
+- 95% confidence intervals required for all primary outcomes and effect sizes.
+- Effect sizes with units and descriptive interpretation.
+- Report both statistical and clinical significance.
+- Pre-specify sensitivity analyses; report robustness across pre-specified analyses.
+
+---
+
+## Figure and Table Requirements
+
+- **Format:** Figures as PPT, PDF, GIF, JPG, or TIFF; tables in separate file
+- **Resolution:** 300 DPI minimum for raster images; 600 DPI for line art
+- **Color:** Color in online publication; design for grayscale legibility if possible
+- **Maximum figures:** 6 for original articles; 4 for case reports; 3 for brief communications
+- **Graphical abstract:** Optional for Original/Case/Review article types; PPT/PDF/GIF/JPG/TIFF; editing fee included in APC
+- **Tables:** Uploaded separately, not embedded in main body docx
+
+---
+
+## Formatting Notes
+
+- **Font:** Times New Roman 11 pt, double-spaced
+- **References:** Vancouver style; EndNote style file (`jkms.ens`) provided in author-guideline package
+- **Units:** SI units throughout
+- **Abbreviations:** Define at first use; minimize use of abbreviations
+- **Tables/Figures:** Reference as "Table 1", "Figure 1" (Title Case + space)
+
+---
+
+## Required Supporting Documents (Submission Package)
+
+| Document | Provided template | Notes |
+|---|---|---|
+| Title page | `Style Guide for JKMS Title` template (.docx) | Title, short title, authors with ORCID, affiliations, corresponding author, funding |
+| Main body | `Style Guide for JKMS Text` template (.docx) | IMRAD layout |
+| Cover letter | `Style Guide for JKMS cover letter` template (.docx) | Addressed to EIC; scientific value, COI, ethics, duplicate-submission, authorship declarations |
+| Tables | Separate file | Not embedded in body |
+| Figures | Separate upload | PPT/PDF/GIF/JPG/TIFF |
+| ICMJE Disclosure Form | Per author (ICMJE standard 13-item) | All authors complete and sign |
+| CRediT contributor role taxonomy | Required | Standardized author role declarations |
+| Data sharing statement | Required (post-July 2018) | ICMJE-compliant |
+
+---
+
+## Common Rejection Reasons
+
+1. **Out of scope** — JKMS is a generalist medical journal; submissions narrowly focused on a single specialty without broader medical relevance may be deprioritized.
+2. **Word count overrun** — 3,000-word main body limit is strictly enforced; manuscripts substantially exceeding this are returned for revision before review.
+3. **Insufficient ethics documentation** — IRB number, Helsinki declaration, and (where applicable) trial registration are all required at submission.
+4. **Reference format non-compliance** — Vancouver style with EndNote `jkms.ens` is expected; hand-typed or inconsistent reference lists trigger pre-review return.
+5. **Missing Data Availability Statement** — mandatory for submissions after July 2018; reviewers and editors check this.
+6. **AI use undisclosed** — generative-AI assistance must be declared in cover letter; failure to disclose triggers ethics review.
+
+---
+
+## Positioning
+
+JKMS is well-suited for:
+- Korean and East Asian population studies with broad medical relevance
+- Single-institution observational studies, particularly those generating clinically actionable evidence
+- Studies on diseases prevalent in Korea or with public-health significance
+- Cross-disciplinary work spanning multiple medical specialties
+- Studies with rigorous methodology and clear clinical implications that fit within a 3,000-word format
+
+**Typical timeline:** Initial review ~8 weeks; revision deadline 2 months; acceptance to online publication 4–6 weeks.
+
+**Cascade considerations:** Cascade rejection policy not explicitly documented; suitable as a primary submission target or as a fallback after rejection from higher-impact generalist journals.
+
+---
+
+## AI Disclosure Policy
+
+- Generative AI assistance (writing aids, language editing) must be disclosed in the cover letter
+- AI cannot be listed as an author
+- AI-generated images require prior editor permission (refer to journal communication policy)
+- Generative AI was not used to create or alter images, figures, or tables (declared in cover letter when applicable)
+
+---
+
+## Author Guidelines URL
+
+https://jkms.org (Author Information section); detailed PDF: JKMS-Information-202602.pdf (distributed with submission package)
+
+---
+
+## Submission Portal
+
+https://submit.jkms.org
+
+---
+
+## Contact
+
+- Editorial office email: jkms@kams.or.kr
+- For technical submission issues, use the portal's help system
+
+---
+
+## Submission verification log (verified 2026-06-03, Original Article)
+
+End-to-end submission learnings — use as the JKMS submission checklist.
+
+**References (author-guide ≠ Zotero CSL):**
+- Format: **superscript** Arabic numerals · **NLM abbreviation** (`Ann Intern Med`) · **no DOI** · ≤6 authors then `et al.` · **year only** (no month/day) · issue `(n)` · `J Abbrev Year;Vol(Issue):Page.` (no period after abbrev).
+- Zotero `journal-of-korean-medical-science.csl` is a **stub → nlm-citation-sequence (parenthetical, keeps DOI, full journal name)** — does NOT match the author guide. Use `manage-refs/citation_styles/journal-of-korean-medical-science-strict.csl` for the pandoc render; validate with `check_csl_render.py --journal jkms`.
+- NLM abbreviations require a `shortjournal` field — populate via `fill_journal_abbrev.py` (PubMed esummary `source`). Authoritative titles (proper-noun casing + subtitle) via PubMed efetch ArticleTitle, double-braced. Particles braced (`{de Torres}`).
+
+**File structure:**
+- Title page (WITH author details) + Main body (NO author details — blinded) uploaded separately.
+- Main body needs **consecutive page numbers + continuous line numbers**.
+- Figures separate (PPT/PDF, panel labels A/B/C); Tables at end of text. Sequence: …Discussion → **References → Figure legends → Tables**.
+- Structured abstract ≤350 (Background/Methods/Results/Conclusion); main text ≤3,000; keywords 3–5 capitalized semicolon MeSH.
+
+**Graphical Abstract (required for Original Articles):**
+- JKMS provides **no fixed template**; after acceptance an external illustrator re-styles it (fee in APC). Submit a clear **draft** (PPT, separated objects) — illustrator edits faster when figure/conclusion/numbers are placed explicitly.
+- Build non-AI (matplotlib + Servier/BioArt) per `journal-ai-image-policies`. 4-block layout (Purpose/Methods/Results/Conclusions) works well. python-pptx + Mac-compat (`app.xml` sync, no TIFF).
+
+**Portal declaration answers (typical observational study):**
+- Article type Original Article · subspecialty leaf (e.g. 23.1.3 Chest Radiology) · IRB Yes + approval# + consent-waiver text · COI per ICMJE · AI use Yes→Proofreading (**must match manuscript AI disclosure** — never tick Statistics/Analysis if disclosure says otherwise) · Professional English proofreading No (unless paid service) · Suggested reviewers optional.
+- **"Submitted elsewhere?"** — cascade (prior reject → JKMS) is sequential not simultaneous → **No** for "currently/under consideration"; **Yes** only for "ever/previously". Check project cascade history (`submission-portal-verification.md` §2B).
+- Corresponding **Tel is a required portal field**; JKMS Information also wants phone on the title page.
+- ICMJE COI form per author (all). Co-first = "First Author" ×N + title-page equal-contribution footnote.
+
+**DOI hyperlink pitfall:** surgical docx reference replacement leaves `<w:hyperlink>` DOIs that `p.runs` misses — strip them, verify via PDF proof (`submission-portal-verification.md` §1).

package/skills/write-paper/references/journal_profiles/JMIR.md

@@ -0,0 +1,88 @@
+# Journal of Medical Internet Research
+
+## Journal Identity
+
+- **Full name**: Journal of Medical Internet Research
+- **Abbreviation**: J Med Internet Res
+- **Publisher**: JMIR Publications (Toronto, Canada)
+- **ISSN**: 1438-8871
+- **Frequency**: Continuous (online only)
+- **Impact Factor**: Ranked #1 in Medical Informatics (Google Scholar)
+- **Open Access**: Yes (Gold OA)
+- **APC**: USD 3,350 (Original Paper); USD 2,680 (Viewpoint); USD 1,675 (Research Letter)
+
+## Manuscript Types and Word Limits
+
+| Type | Abstract | Manuscript Body | References | Figures/Tables |
+|------|----------|----------------|------------|----------------|
+| Original Paper | Structured | IMRD format | No cap | No strict cap |
+| Digital Health Review | Structured | No strict cap | No cap | No strict cap |
+| Viewpoint/Perspective | Varies | No strict cap | No cap | No strict cap |
+| Research Letter | Structured | 1,000 | 10 | 2 |
+| Letter to the Editor | None | Short | No cap | None |
+| Policy Paper | Varies | No strict cap | No cap | No strict cap |
+
+## Abstract Format
+
+Structured, following JMIR abstract guidelines (for original research).
+
+## Keywords
+
+Required after abstract.
+
+## Required Sections
+
+1. **Introduction**
+2. **Methods** (subheadings: Study Design, Recruitment, Analysis, Ethical Considerations)
+3. **Results** (subheadings mirror Methods)
+4. **Discussion** (subheadings: Principal Results, Limitations, Comparison with Prior Work, Conclusions)
+5. **Acknowledgements**
+6. **Funding Statement**
+7. **Conflicts of Interest**
+8. **Data Availability**
+9. **Authors' Contributions**
+10. **Abbreviations**
+11. **Multimedia Appendices** (optional)
+12. **References**
+
+## Citation Style
+
+- AMA (American Medical Association) style, 11th edition
+- No bare URLs in body text; all URLs cited as references
+- Use JMIR/AMA journal style in reference managers
+
+## Reporting Guidelines
+
+| Study Type | Required Checklist |
+|------------|-------------------|
+| Randomized trials | CONSORT |
+| Systematic reviews | PRISMA / QUORUM |
+| Scoping reviews | Applicable checklist |
+| Machine learning studies | ML reporting guidelines |
+
+Upload completed checklists as Multimedia Appendix.
+
+## Statistical Reporting
+
+Follows ICMJE statistical reporting recommendations:
+- Report exact p-values; use P < .001 for values below that threshold.
+- 95% CI required for primary outcomes.
+- For ML studies: independent validation dataset required; performance metrics (AUC, sensitivity, specificity) with 95% CI.
+- Effect sizes and confidence intervals preferred over p-values alone for clinical meaningfulness.
+- Statistical software and version must be identified in Methods.
+- No journal-specific statistical reporting requirements beyond ICMJE and study-type guidelines (CONSORT, PRISMA) are published.
+
+## Special Notes
+
+- **Highly selective flagship journal** of JMIR Publications.
+- **Scope**: digital health, health informatics, emerging technologies. ML papers accepted only if showing direct clinical impact with independent validation dataset.
+- **ORCID required** for all authors at time of publication.
+- **File format**: Microsoft Word only (.doc/.docx).
+- **Figures/tables**: placed within text, not at end.
+- **No URLs in body text**: all must be cited as references.
+- **Cascading peer review**: rejected papers may transfer to JMIR sister journals (with reviews).
+- **Fast-track option**: 4-week turnaround from submission to initial decision.
+- **Topical routing**: clinical informatics must connect to consumer/patient empowerment; pure clinical informatics goes to JMIR sister journals.
+- **10% content overlap** may be flagged as duplicative.
+- **Preprints accepted**: disclose in cover letter.
+- Standard review time: less than 2 months.

package/skills/write-paper/references/journal_profiles/JMIR_Medical_Education.md

@@ -0,0 +1,86 @@
+# JMIR Medical Education
+
+## Journal Identity
+
+- **Full name**: JMIR Medical Education
+- **Abbreviation**: JMIR Med Educ
+- **Publisher**: JMIR Publications
+- **ISSN**: 2369-3762
+- **Frequency**: Continuous (online only)
+- **Impact Factor**: ~12.6 (2024)
+- **Open Access**: Yes (CC BY 4.0)
+- **APC**: See JMIR fee schedule (varies by article type)
+
+## Manuscript Types and Word Limits
+
+| Type | Abstract | Manuscript Body | References | Notes |
+|------|----------|----------------|------------|-------|
+| Original Paper | Structured | IMRD format | No cap | Primary research |
+| Review | Structured | No strict cap | No cap | Systematic, scoping reviews |
+| Viewpoint | Varies | No strict cap | No cap | Opinion/perspective |
+| Policy Paper | Varies | No strict cap | No cap | Policy issues in med ed |
+| Students' Corner | Varies | Short | No cap | By students/trainees |
+
+## Abstract Format
+
+Structured, following JMIR abstract guidelines.
+For original papers, must align with IMRD structure.
+
+## Keywords
+
+Required after abstract. Follow JMIR keyword guidelines.
+
+## Required Sections
+
+1. **Introduction**
+2. **Methods** (subheadings: Study Design, Recruitment, Analysis, Ethical Considerations)
+3. **Results** (subheadings should mirror Methods)
+4. **Discussion** (subheadings: Principal Results, Limitations, Comparison with Prior Work, Conclusions)
+5. **Acknowledgments**
+6. **Funding Statement** (separate from Acknowledgments)
+7. **Conflicts of Interest** (mandatory; "None declared" if none)
+8. **Data Availability**
+9. **Author Contributions**
+10. **Abbreviations**
+11. **Multimedia Appendix** (optional)
+12. **References**
+
+## Citation Style
+
+- AMA (American Medical Association) style, 11th edition
+- No bare URLs in body text; all URLs cited as references
+- Use JMIR/AMA journal style in reference managers (e.g., EndNote)
+
+## Reporting Guidelines
+
+| Study Type | Required Checklist |
+|------------|-------------------|
+| Randomized trials | CONSORT |
+| Systematic reviews | PRISMA |
+| Scoping reviews | Applicable checklist |
+
+Upload completed checklists as Multimedia Appendix.
+
+## Statistical Reporting
+
+Follows ICMJE statistical reporting conventions:
+- Report exact p-values; avoid reporting only P < .05.
+- 95% CI required for primary outcomes in quantitative studies.
+- For educational effectiveness studies: effect sizes (Cohen's d or equivalent) required alongside p-values; distinguish clinical/educational significance from statistical significance.
+- For qualitative studies: no quantitative reporting requirements; follow COREQ or SRQR.
+- Statistical software and version must be named in Methods.
+- No journal-specific statistical reporting requirements beyond ICMJE are published.
+
+## Special Notes
+
+- **Single-blind review** with named reviewers (reviewer names published with accepted articles).
+- **ORCID required** for all authors at time of publication.
+- **File format**: Microsoft Word only (.doc/.docx).
+- **Figures/tables**: placed within text (not at end), portrait orientation only.
+- **No URLs in body text**: all must be cited as references.
+- **Cascading peer review**: rejected papers may be transferred to JMIR sister journals.
+- **Fast-track option**: editorial decision within 20 working days (additional fee).
+- **Ethical Considerations** subsection mandatory in Methods for studies involving human subjects.
+- **10% content overlap** with prior work may be flagged as duplicative.
+- **Generative AI use** must be disclosed per JMIR AI policy.
+- Style emphasis: use *italics* for emphasis, not bold or underline.